Phrenic Nerve Infiltration in Neck Pain
Launched by UNIVERSITY OF SEVILLE · Oct 30, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a treatment called phrenic nerve infiltration for people suffering from chronic neck pain. The phrenic nerve is connected to certain organs in the chest, and issues with these organs can sometimes cause pain that feels like it's coming from the neck. The goal of this study is to see if injecting medicine into the phrenic nerve can help reduce pain and improve neck symptoms for patients who do not have underlying neurological, traumatic, or infectious conditions that explain their pain.
To participate in this trial, you need to be between the ages of 18 and 64 and have neck pain as your main complaint. You should also have a condition related to the organs near the diaphragm. However, this study is not for everyone; for example, people with certain severe illnesses or recent treatments for neck pain cannot join. If eligible, participants will receive treatment and be monitored to see how well it works. This study is currently recruiting, and it's a great opportunity for those struggling with chronic neck pain to explore a new potential solution.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 and under 64 years old
- • Patients attending to the physician or physical therapist with a main complaint of neck pain
- • Presentation of any peridiaphragmatic visceral disorder.
- • That the subject agrees to participate in the project by signing the informed consent.
- Exclusion Criteria:
- • Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin.
- • Uncooperative subject.
- • Severe psychiatric illness.
- • Loss of Cognitive Ability.
- • Contraindication to infiltration of the phrenic nerve.
- • History of head, spinal or upper limb surgery
- • History of infiltration for the neck pain in the previous 3 months
- • History of physical therapy for the neck pain in the previous 30 days
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dos Hermanas, Seville, Spain
Seville, , Spain
Patients applied
Trial Officials
Angel Oliva Pascual-Vaca, Dr
Principal Investigator
University of Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials